Chandan Group

India Founded: 1991 • Age: 35 yrs Listed
Healthcare services encompassing diagnostics, pharmacies, hospitals, and pharmaceuticals in India.
Request Access
Report Incorrect Data
Page last updated

About Chandan Group

Chandan Group is a publicly listed company based in India founded in 1991. Healthcare services encompassing diagnostics, pharmacies, hospitals, and pharmaceuticals in India. Its Indian entity Chandan Healthcare Limited reported revenue of ₹281 Cr. Chandan Group offers products and services including Diagnostic Services and Pharmacy Services. Its focus areas include Medical Services, Diagnostics, Diagnostic Centers and Pharmaceuticals.

Company details

Chandan Group has been active since 1991, where diagnostics, pharmacies, hospitals, pharmaceuticals, and medical education are provided to over 30 million patients, with more than 3 million served annually. Operations include over 50 diagnostic centers and 500 collection centers across states like Uttar Pradesh and Uttarakhand, supported by a workforce of over 3,000. Hospitals with capacities exceeding 300 beds are maintained, and expansions to 600 beds are planned, while pharmaceuticals are produced under strict quality controls to enhance accessibility in healthcare.

  • Headquarters India
  • Stage Public
  • Sectors
    Healthcare
  • Legal Name Chandan Healthcare Ltd
  • Date of Incorporation 03 Sep, 2003
  • Jurisdiction Lucknow, Uttar Pradesh, India
Operational Areas
Healthcare → Diagnostics Laboratories
Healthcare → Pharmaceuticals & Distribution
Key Metrics
  • Market Cap
    ₹560 Cr

    CHANDAN-SM · NSE

  • Share Price
    ₹218.60

    -4.54% today

  • Revenue
    ₹276 Cr

    FY 2025-26 · +20.1% YoY

  • EBITDA
    ₹57.21 Cr

    Margin 20.7%

  • Net Profit
    ₹19.40 Cr

    FY 2025-26 · -12.5% YoY

  • P/E (TTM)
    21.3x

    P/B 3.3x

Products & Services of Chandan Group

Chandan Group offers a comprehensive portfolio of products and services, including Diagnostic Services and Pharmacy Services.

Diagnostic Services
Healthcare Services

Diagnostic services are offered in specialties such as Radiology and Pathology across multiple centers.

Pharmacy Services
Retail and Wholesale

Quality medications are distributed through retail and wholesale channels to support medical needs.

Board of directors of Chandan Healthcare Limited (Chandan Group)

Chandan Healthcare Limited is the primary company behind Chandan Group. The board of Chandan Healthcare Limited currently have 7 directors; the longest-serving is Amar Singh, appointed in 2003. 22 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Amar Singh
DIN 01096328
Managing Director03 Sep 200323 yrs 1 moChandan Healthcare Limited
Asmita Singh
DIN 01098055
Managing Director03 Sep 200323 yrs 1 moChandan Healthcare Limited
Vinay Lamba
DIN 01220153
Director03 Sep 200323 yrs 1 moChandan Healthcare Limited
Amit Gupta
DIN 00583538
Director13 Aug 20242 yrs 2 moChandan Healthcare Limited
Vinod Jain
DIN 10701178
Director13 Aug 20242 yrs 2 moChandan Healthcare Limited
Brahma Nand Bhartiya
DIN 10729411
Director13 Aug 20242 yrs 2 moChandan Healthcare Limited
Sanjay Srivastava
DIN 11927967
Director07 Sep 20261 moChandan Healthcare Limited

People of Chandan Group

2 people are tracked at Chandan Group (1 in leadership, 1 in team).

NameRoleGroup
Amar Singh
Chairman & Managing DirectorLeadership
Himanshu Pandey
Legal ManagerTeam
Premium access

Complete people profiles for Chandan Group

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Chandan Group

Chandan Group is a publicly listed company on the NSE with ticker symbol CHANDAN in India, operating in the Healthcare sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • Listed onNSE: CHANDAN
  • Listed entityChandan Healthcare Limited
  • Exchange sectorHealthcare

Financials of Chandan Group

Exchange-reported figures of Chandan Healthcare Limited, the listed company behind Chandan Group (NSE: CHANDAN-SM).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹276 Cr
+20.1% YoY
EBITDA
₹57.21 Cr
+38.4% YoY
Profit After Tax
₹19.40 Cr
-12.5% YoY
Net Worth
₹171 Cr
+39.5% YoY
Total Assets
₹235 Cr
+31.8% YoY
Total Debt
₹53.75 Cr
+11.6% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Income statement
Revenue276230177137120
Revenue growth+20.1%+30.3%+29.0%+14.5%-
EBITDA57.2141.3326.399.372.24
EBITDA margin+20.7%+18.0%+14.9%+6.8%+1.9%
Profit before tax32.2432.0621.465.00(1.08)
Net profit19.4022.1716.273.36(1.13)
Net profit margin+7.0%+9.6%+9.2%+2.5%-1.0%
EPS (₹)7.729.078.141.68(0.55)
Balance sheet
Total assets23517882.5953.6145.22
Net worth17112341.1627.3023.93
Total debt53.7548.1635.9121.3616.58
Cash & bank3.586.213.902.041.58
Net working capital10063.6227.257.557.93
Cash flow
Cash from operations16.17(2.75)1.124.506.10
Cash from investing(39.90)(62.04)(14.83)(6.49)(10.75)
Cash from financing21.1067.1115.572.463.48
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue80.8575.5865.0167.9067.9062.6554.64
Revenue growth (YoY)+19.1%+20.6%+19.0%----
Other income1.411.850.770.840.872.420.17
EBITDA19.5711.479.6214.1513.8710.238.89
EBITDA margin+24.2%+15.2%+14.8%+20.8%+20.4%+16.3%+16.3%
Depreciation4.473.742.402.463.752.701.35
Interest4.831.781.281.401.371.301.09
Profit before tax11.687.806.7111.139.628.656.62
Tax3.782.861.672.873.432.562.00
Net profit7.904.945.048.266.196.094.62
EPS (₹)2.591.951.863.192.302.640.00
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue15712999.8775.8371.6055.9566.56
Revenue growth+21.3%+29.3%+31.7%+5.9%+28.0%-15.9%-
EBITDA43.7236.8325.439.312.734.946.21
EBITDA margin+27.9%+28.5%+25.5%+12.3%+3.8%+8.8%+9.3%
Profit before tax33.9128.1520.965.27(0.71)1.472.35
Net profit27.3820.7616.014.05(1.44)0.811.43
Net profit margin+17.5%+16.1%+16.0%+5.3%-2.0%+1.5%+2.2%
EPS (₹)10.088.508.012.02(0.69)0.410.71
Balance sheet
Total assets21115772.5945.2937.9938.7038.62
Net worth16712140.6726.6522.6124.9423.96
Total debt39.0233.2029.0816.5815.3813.7514.66
Cash & bank3.146.030.531.541.962.442.12
Net working capital78.1044.5913.66(3.69)(1.12)7.66(1.87)
Cash flow
Cash from operations24.166.385.854.747.49(6.63)-
Cash from investing(49.85)(60.86)(15.36)(2.20)(9.52)7.45-
Cash from financing22.7959.998.51(2.00)(1.83)(0.50)-
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue48.6744.7735.7038.0935.8837.0529.52
Revenue growth (YoY)+35.7%+20.8%+20.9%----
Other income1.092.000.680.730.751.900.05
Total expenses31.5634.1127.7525.5324.2826.6722.13
EBITDA17.1110.667.9512.5611.6010.387.39
EBITDA margin+35.2%+23.8%+22.3%+33.0%+32.3%+28.0%+25.0%
Depreciation4.182.342.372.402.922.421.34
Interest4.061.370.941.060.990.980.86
Profit before tax9.968.955.329.838.448.885.24
Tax3.242.131.352.533.062.471.64

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 24 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue80.8575.5865.0167.9067.9062.6554.64
Revenue growth (YoY)+19.1%+20.6%+19.0%----
Other income1.411.850.770.840.872.420.17
EBITDA19.5711.479.6214.1513.8710.238.89
EBITDA margin+24.2%+15.2%+14.8%+20.8%+20.4%+16.3%+16.3%
Depreciation4.473.742.402.463.752.701.35
Interest4.831.781.281.401.371.301.09
Profit before tax11.687.806.7111.139.628.656.62
Tax3.782.861.672.873.432.562.00
Net profit7.904.945.048.266.196.094.62
EPS (₹)2.591.951.863.192.302.640.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Revenue276230177137120
Revenue growth+20.1%+30.3%+29.0%+14.5%-
Other income4.392.051.220.140.35
Total expenses219189150128117
Employee cost0.0038.8635.4225.4918.73
EBITDA57.2141.3326.399.372.24
EBITDA margin+20.7%+18.0%+14.9%+6.8%+1.9%
Depreciation14.936.743.402.091.96
Interest14.434.582.752.421.71
Profit before tax32.2432.0621.465.00(1.08)
Tax11.968.555.111.420.03
Net profit19.4022.1716.273.36(1.13)
Net profit margin+7.0%+9.6%+9.2%+2.5%-1.0%
EPS (₹)7.729.078.141.68(0.55)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Equity & liabilities
Share capital24.4524.4520.0020.0020.00
Reserves & surplus14598.1521.167.303.93
Shareholders' funds (net worth)17112341.1627.3023.93
Minority interest5.303.812.462.762.54
Secured loans53.7548.1635.9121.3616.56
Unsecured loans0.000.000.000.000.02
Total debt53.7548.1635.9121.3616.58
Total liabilities23517882.5953.6145.22
Assets
Gross block15411984.2764.9359.65
Net block10176.3548.4932.5529.36
Capital work in progress11.994.100.000.000.00
Investments19.9633.153.387.406.11
Inventories34.0831.7018.319.876.56
Sundry debtors86.4047.2628.6123.6928.70
Cash & bank balances3.586.213.902.041.58
Loans & advances28.889.8010.5815.096.32
Total current assets15394.9761.4050.6943.16
Total current liabilities52.8331.3534.1543.1435.23
Net working capital10063.6227.257.557.93
Total assets23517882.5953.6145.22
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Opening cash6.213.902.041.582.75
Net cash from operating activities16.17(2.75)1.124.506.10
Net cash from investing activities(39.90)(62.04)(14.83)(6.49)(10.75)
Net cash from financing activities21.1067.1115.572.463.48
Net change in cash(2.63)2.311.860.47(1.17)
Closing cash3.586.213.902.041.58
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Growth
Sales growth+20.1%+30.3%+29.0%+14.5%-
EBITDA growth+38.4%+56.6%+181.6%+318.3%-
PBT growth+0.6%+49.4%+329.2%+9998.0%+9997.0%
Net income growth-12.5%+36.3%+384.2%+397.4%-
Revenue CAGR (3Y)+26.4%+24.4%---
EBITDA CAGR (3Y)+82.8%+164.2%---
Profitability & leverage
Net income margin+7.3%+10.2%+9.3%+2.6%-0.9%
Return on capital employed-+28.8%+37.0%+15.9%+1.5%
Return on net worth-+28.7%+47.8%+14.0%-4.6%
Debt / equity-0.510.840.740.69
Long-term debt / equity-0.210.290.280.00
Interest cover34.1313.2411.9633.24610.71
Efficiency & per share
Fixed asset turnover-2.272.372.202.00
Inventory turnover-9.2012.5316.6618.23
Debtors turnover-6.116.755.234.17
EPS (₹)7.729.078.141.68(0.55)
Dividend per share (₹)0.000.000.000.000.00
Book value per share (₹)0.0050.1420.5813.6511.97
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue48.6744.7735.7038.0935.8837.0529.52
Revenue growth (YoY)+35.7%+20.8%+20.9%----
Other income1.092.000.680.730.751.900.05
Total expenses31.5634.1127.7525.5324.2826.6722.13
EBITDA17.1110.667.9512.5611.6010.387.39
EBITDA margin+35.2%+23.8%+22.3%+33.0%+32.3%+28.0%+25.0%
Depreciation4.182.342.372.402.922.421.34
Interest4.061.370.941.060.990.980.86
Profit before tax9.968.955.329.838.448.885.24
Tax3.242.131.352.533.062.471.64
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue15712999.8775.8371.6055.9566.56
Revenue growth+21.3%+29.3%+31.7%+5.9%+28.0%-15.9%-
Other income4.131.311.000.090.200.080.23
Total expenses11392.3374.4466.5268.8751.0160.35
Employee cost0.0033.3930.4619.6714.2711.2214.74
EBITDA43.7236.8325.439.312.734.946.21
EBITDA margin+27.9%+28.5%+25.5%+12.3%+3.8%+8.8%+9.3%
Depreciation9.516.423.362.051.951.542.31
Interest4.433.572.112.081.692.011.78
Profit before tax33.9128.1520.965.27(0.71)1.472.35
Tax8.567.394.951.220.660.660.92
Net profit27.3820.7616.014.05(1.44)0.811.43
Net profit margin+17.5%+16.1%+16.0%+5.3%-2.0%+1.5%+2.2%
EPS (₹)10.088.508.012.02(0.69)0.410.71
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital24.4524.4520.0020.0020.0020.0020.00
Reserves & surplus14296.2620.676.652.614.943.96
Shareholders' funds (net worth)16712140.6726.6522.6124.9423.96
Secured loans39.0233.2029.0815.3115.3713.4912.12
Unsecured loans0.000.000.001.270.010.262.54
Total debt39.0233.2029.0816.5815.3813.7514.66
Total liabilities21115772.5945.2937.9938.7038.62
Assets
Gross block14511177.1158.8352.2346.7845.40
Net block95.7471.4843.5327.7324.8120.1620.32
Capital work in progress11.904.100.000.000.000.000.00
Investments24.1936.5812.5515.4114.1211.0319.93
Inventories16.3917.286.520.361.232.694.69
Sundry debtors44.2231.3121.8615.9010.4411.669.83
Cash & bank balances3.146.030.531.541.962.442.12
Loans & advances33.888.063.821.425.587.191.03
Total current assets97.6362.6832.7319.2219.2123.9817.67
Total current liabilities19.5318.0919.0722.9120.3316.3219.54
Net working capital78.1044.5913.66(3.69)(1.12)7.66(1.87)
Total assets21115772.5945.2937.9938.7038.62
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash6.030.531.541.005.822.12-
Net cash from operating activities24.166.385.854.747.49(6.63)-
Net cash from investing activities(49.85)(60.86)(15.36)(2.20)(9.52)7.45-
Net cash from financing activities22.7959.998.51(2.00)(1.83)(0.50)-
Net change in cash(2.90)5.50(1.01)0.54(3.85)0.32-
Closing cash3.146.030.531.541.962.44-
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+21.3%+29.3%+31.7%+5.9%+28.0%-15.9%-
EBITDA growth+18.7%+44.8%+173.2%+241.0%-44.7%-20.5%-
PBT growth+20.5%+34.3%+297.7%+9998.0%--37.5%+9997.0%
Net income growth+31.9%+29.7%+295.3%+381.3%-277.8%-43.4%-
Revenue CAGR (3Y)+27.4%+21.7%+21.3%+4.4%---
EBITDA CAGR (3Y)+67.5%+138.1%+72.7%+14.5%---
Profitability & leverage
Net income margin+16.2%+16.1%+16.0%+5.3%-1.9%+1.5%+2.2%
Return on capital employed-+27.6%+39.2%+17.6%+2.6%+9.0%+10.6%
Return on net worth-+25.8%+47.6%+16.4%-5.8%+3.4%+5.9%
Debt / equity-0.390.680.650.610.580.61
Long-term debt / equity-0.210.300.300.290.310.34
Interest cover12.9511.749.5628.65216.6759.1245.64
Efficiency & per share
Fixed asset turnover-1.371.471.371.451.211.47
Inventory turnover-10.8529.0395.3836.5315.1614.19
Debtors turnover-4.865.295.766.485.216.77
EPS (₹)10.088.508.012.02(0.69)0.410.71
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)0.0049.3720.3313.3311.3012.4711.98

Web traffic of Chandan Group

Websites that share an audience with Chandan Group (chandan.co.in).

Similar websites

Websites whose visitors overlap most with Chandan Group. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
Chandan Diagnostic
chandandiagnostic.com
100%
11.1KView details
Sahara Hospital
saharahospitals.com
96%
View details

Top companies in Diagnostics Laboratories

3 companies that operate in the same segment as Chandan Group (Diagnostics Laboratories) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Thyrocare
Diagnostic testing centers for pathology and health screenings are operated.
1996Mumbai, Maharashtra, IndiaUSD 63.59 MUSD 88.36 M1,950
Dr Lal PathLabs
Chain of pathology and radiology labs
1949Gurugram, Haryana, IndiaUSD 13.9 MUSD 294.49 M5,310
Redcliffe Labs
Home-based diagnostic tests are booked via an online platform.
2018Noida, Uttar Pradesh, IndiaUSD 116.42 MUSD 41.86 M2,308
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Chandan Group

Chandan Healthcare Acquires Two Ansh Diagnostics Units In Ghaziabad – Outlook Business
Outlook Business • 24 days ago
Chandan Healthcare Scales Franchise Network To 500+ Franchises; Targets 1,000 Franchises By FY27-End – Outlook Business
Outlook Business • 1 month ago
Chandan Healthcare consolidated net profit rises 29.53% in the June 2026 quarter | Capital Market News - Business Standard
Business Standard • 2 months ago
Premium access

Complete news archive for Chandan Group

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandan Group

Chandan Group was founded in 1991.

Chandan Group is headquartered in India.

The primary company behind Chandan Group, Chandan Healthcare Limited, reported revenue of ₹281 Cr for FY 2026, up 20% year on year.

Chandan Group has been active since 1991, where diagnostics, pharmacies, hospitals, pharmaceuticals, and medical education are provided to over 30 million patients, with more than 3 million served annually. Operations include over 50 diagnostic centers and 500 collection centers across states like Uttar Pradesh and Uttarakhand, supported by a workforce of over 3,000. Hospitals with capacities exceeding 300 beds are maintained, and expansions to 600 beds are planned, while pharmaceuticals are produced under strict quality controls to enhance accessibility in healthcare.

Chandan Group offers Diagnostic Services and Pharmacy Services.

Yes, Chandan Group is publicly traded on NSE under the ticker symbol CHANDAN.

Chandan Group operates through Chandan Healthcare Limited.

The legal entities of Chandan Group currently have 8 directors, including Amar Singh, Asmita Singh, Vinay Lamba and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available